The IMNOVID brand, founded in 2011 (United States), from 126 sister brands and 17477 competing brands. IMNOVID is owned by Celgene, listed on the stock exchange of New York IMNOVID is part of the Drug Manufacturers activity sector.
Share price brand.technical-problem
Yield (Dividend per share)
(2019-2023) Stoxx Europe 600 : +36.90 % S&P 500 NY : +84.20 %